IPAB draws sustained opposition from GOP, health industry lobbyists

The Independent Payment Advisory Board, which is one of the health law's central tools for cutting Medicare costs, continues to be a topic that draws significant opposition.

The Washington Post: Republicans, Health Industry Lobbyists Target Medicare Cost-Cutting Board
Even as congressional leaders launch the "super committee" charged with making major inroads with the nation's debt, Republicans and health industry lobbyists are waging a sustained campaign against a panel with notably similar goals and powers that is a centerpiece of the new health care law. Known as the Independent Payment Advisory Board, or IPAB, it has been touted by President Obama as an essential tool for curbing Medicare spending over the long term (Aizenman, 8/13).

Earlier, related KHN coverage: The IPAB: How Will It Change Medicare? (Vaida, 5/8).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.

or

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study examines potential impact of the Medicare Prescription Payment Plan on cancer patients